Why Did Ekso Bionics Plunge 31.35%? Revenue Drops 58%

On July 29, 2025, Ekso Bionics experienced a significant drop of 31.35% in pre-market trading, reflecting a substantial decline in investor confidence.

Ekso Bionics reported a significant decline in revenue for the second quarter of 2025, falling to $2.1 million from $5.0 million in the same period of 2024. This represents a 58% year-over-year decrease, primarily attributed to delays in multi-device Enterprise Health sales. The company's earnings per share loss for the quarter was $(1.24), which was narrower than expected.

Despite the overall revenue decline, Ekso Bionics saw growth in its Personal Health product revenues, which increased by more than 50% for the first half of 2025. This growth was driven by the company's AI-powered rehabilitation push, which has been a key focus area for Ekso Bionics.

The company's stock saw a 6.02% decline during the day, followed by a 7.05% rise in aftermarket trading, indicating a mixed reaction from investors to the financial results and the company's strategic initiatives.